Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a content update.
    Difference
    0.0%
    Check dated 2026-04-30T08:48:44.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-15T22:09:38.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T06:59:28.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-10T15:40:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Administrative revision updates were applied: Revision v3.4.2 was added and Revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T03:05:12.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the government-funding notice and the earlier Revision: v3.4.0 entry.
    Difference
    0.1%
    Check dated 2026-02-09T21:40:17.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.